Dimensional Fund Advisors
EIDX

Dimensional Fund Advisors’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Dimensional Fund Advisors’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-11,646
Closed -$1.53M – 3446
2020
Q4 		$1.53M Sell
11,646
-255
-2% -$22.5K ﹤0.01% 2883
2020
Q3 		$601K Buy
11,901
+5,106
+75% +$230K ﹤0.01% 3024
2020
Q2 		$324K Buy
+6,795
New +$316K ﹤0.01% 3148
2020
Q1 		– Sell
-5,405
Closed -$310K – 3403
2019
Q4 		$310K Buy
+5,405
New +$268K ﹤0.01% 3208

Dimensional Fund Advisors's EIDX Position: Q1 2021 in Review

Dimensional Fund Advisors sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 11,646 shares — an estimated $1.53M sold.

Dimensional Fund Advisors first reported a position in EIDX in Q4 2019 and held it in 4 quarters. The position peaked at $1.53M in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

  • Dimensional Fund Advisors reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Dimensional Fund Advisors sold 11,646 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $1.53M.
  • Dimensional Fund Advisors first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
  • Dimensional Fund Advisors's Eidos Therapeutics, Inc. Common Stock position peaked at $1.53M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Dimensional Fund Advisors's 13F filing for Q1 2021, filed 14 May 2021.